Page last updated: 2024-08-22

buthionine sulfoximine and Adenoma Sebaceum

buthionine sulfoximine has been researched along with Adenoma Sebaceum in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aronica, E; Borkowska, J; Grajkowska, W; Iyer, AM; Jaworski, J; Jozwiak, S; Kotulska, K; Kwiatkowski, DJ; Liszewska, E; Macias, M; Malik, AR; Parobczak, K; Perycz, M; Pietruszka, P; Skalecka, A; Swiech, LJ; Tyburczy, ME; Urbanska, M; Zarebska, MM1

Other Studies

1 other study(ies) available for buthionine sulfoximine and Adenoma Sebaceum

ArticleYear
Tuberous sclerosis complex neuropathology requires glutamate-cysteine ligase.
    Acta neuropathologica communications, 2015, Jul-30, Volume: 3

    Topics: Adolescent; Animals; Brain; Buthionine Sulfoximine; Cell Proliferation; Child; Chlorocebus aethiops; COS Cells; Enzyme Inhibitors; Female; Glutamate-Cysteine Ligase; Green Fluorescent Proteins; Humans; Immunosuppressive Agents; Male; Neurons; RNA, Small Interfering; Sirolimus; TOR Serine-Threonine Kinases; Tuberous Sclerosis; Tuberous Sclerosis Complex 1 Protein; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins; Young Adult

2015